arrow
M

Michael J. Soileau

texas movement disorder specialists, georgetown, texas, usa
H指数:10
被引数:842

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cutaneous Phosphorylated Alpha-Synuclein in Lewy Body Dementia
2025-12-010
OAAI
Improvement in Motor Consistency and Stability with Foslevodopa/Foscarbidopa in Advanced Parkinson’s Disease: Post Hoc Analysis of Two Phase 3 Clinical Trials

在晚期帕金森病中使用Foslevodopa/Foscarbidopa改善运动一致性和稳定性:两项III期临床试验的回顾性分析

2025-10-040
OA
Efficacy and Safety of Foslevodopa/Foscarbidopa Monotherapy in Patients with Parkinson's Disease

帕金森病患者中左旋多巴/卡比多巴福斯汀单药治疗的有效性和安全性

2025-07-300
OA
Accelerated symptom improvement in Parkinson's disease via remote internet-based optimization of deep brain stimulation therapy: a randomized controlled multicenter trial

通过基于互联网的远程优化深部脑刺激治疗加速帕金森病症状改善: 一项随机对照多中心试验

2025-01-310
OAAI
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies
2024-04-1628
OA
The Synuclein-One Study: Skin Biopsy Detection of Phosphorylated alpha-synuclein for Diagnosis of the Synucleinopathies
2023-04-250
PRE
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson's Disease: Real-World Evidence From G7 Countries
2022-01-119
OAAI
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial
2021-09-1498
OA